JS-206

N/A

Report date: 2023/05/22 10:16:39

Base Information

Drug NameJS-206
Drug Alias NameJS-206
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionInterleukin-2 inhibitorsProgrammed cell death protein 1 inhibitors
TargetsInterleukin-2Programmed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Junshi Biological Engineering Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Junshi Biological Engineering Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A